Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2019 - 2026)
Mirum Pharmaceuticals' quarterly Interest & Investment Income came in at $3.4 million in Q1 2026, up 12.5% year-on-year from $3.0 million in Q1 2025, and down 0.56% quarter-over-quarter from $3.4 million in Q4 2025.
Mirum Pharmaceuticals has reported Interest & Investment Income for 8 years, with the latest figure at $3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 12.5% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (down 0.58% YoY), and the FY2025 full-year result was $12.7 million, down 7.72% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.4 million, down from $3.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.1 million in Q3 2023, with the low at $69000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $2.8 million, with a median of $3.3 million recorded in 2025.
- Peak annual rise in Interest & Investment Income reached 3196.92% in 2022, while the deepest fall reached 53.69% in 2022.
- Tracing MIRM's Interest & Investment Income over 5 years: stood at $2.1 million in 2022, then jumped by 76.15% to $3.8 million in 2023, then dropped by 15.13% to $3.2 million in 2024, then advanced by 6.74% to $3.4 million in 2025, then retreated by 0.56% to $3.4 million in 2026.
- The last three Interest & Investment Income figures came in at $3.4 million (Q1 2026), $3.4 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | 3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.06 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 69,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 72,000.00 |
| Jun 30, 2021 | 80,000.00 |
| Mar 31, 2021 | 149,000.00 |
| Dec 31, 2020 | 168,000.00 |
| Sep 30, 2020 | 237,000.00 |
| Jun 30, 2020 | 405,000.00 |
| Mar 31, 2020 | 749,000.00 |
| Dec 31, 2019 | 747,000.00 |
| Sep 30, 2019 | 785,000.00 |
| Jun 30, 2019 | 468,000.00 |
| Mar 31, 2019 | 232,000.00 |